Phase I Study of Intraperitoneal Administration of 9-Amino-20(S)-Camptothecin [IDEC 132] to Patients With Cancer Predominantly Confined to the Peritoneal Cavity
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2005
At a glance
- Drugs IDEC 132 (Primary)
- Indications Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Sep 2005 New trial record.